Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative intravenous insulin, GIK, and liraglutide for glucose control in type 2 diabetes during non-cardiac surgery
NL-OMON43712Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2014
- Modality
- Peptides, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liraglutide, human insulin, glucose and Potassium in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Difference in median glucose 1 hour after surgery. Started Feb 2014; status: active, not recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON43712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43712.